Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir in HCV/HIV Coinfection vs HCV Monoinfection
NCT01443923Phase 4Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of boceprevir in hepatitis C (HCV), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2011; status: terminated.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01443923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443923.